Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2019. Start Trial.
Date Value
October 23, 2026 4.522
October 22, 2026 4.641
October 21, 2026 4.638
October 20, 2026 4.806
October 19, 2026 4.482
October 16, 2026 4.365
October 15, 2026 4.444
October 14, 2026 4.200
October 13, 2026 4.063
October 12, 2026 4.361
October 09, 2026 4.468
October 08, 2026 4.325
October 07, 2026 4.387
October 06, 2026 4.401
October 05, 2026 4.573
October 02, 2026 4.627
October 01, 2026 4.697
September 30, 2026 4.695
September 29, 2026 4.674
September 28, 2026 4.605
September 25, 2026 4.479
September 24, 2026 4.567
September 23, 2026 4.715
September 22, 2026 5.273
September 21, 2026 5.066
Date Value
September 18, 2026 5.134
September 17, 2026 5.224
September 16, 2026 5.040
September 15, 2026 5.084
September 14, 2026 5.346
September 11, 2026 5.243
September 10, 2026 5.298
September 09, 2026 5.403
September 08, 2026 5.427
September 04, 2026 5.383
September 03, 2026 5.416
September 02, 2026 5.508
September 01, 2026 5.578
August 31, 2026 5.634
August 28, 2026 5.710
August 27, 2026 5.886
August 26, 2026 5.976
August 25, 2026 6.043
August 24, 2026 5.837
August 21, 2026 5.831
August 20, 2026 5.671
August 19, 2026 5.965
August 18, 2026 5.804
August 17, 2026 5.802
August 14, 2026 5.647

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 20.32
Anika Therapeutics, Inc. 2.088
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.376

Price to Book Value Related Metrics

PS Ratio 55.84
Price 25.04
Earnings Yield -13.47%
Market Cap 1.563B